Affiliation:
1. Division of Molecular and Cellular Pathology, Department of Pathology University of Alabama at Birmingham Birmingham AL
2. Division of Cardiovascular Disease, Department of Medicine University of Alabama at Birmingham Birmingham AL
3. Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine University of Alabama at Birmingham Birmingham AL
4. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine University of Alabama at Birmingham Birmingham AL
Abstract
Background
Lifestyle and metabolic diseases influence the severity and pathogenesis of cardiovascular disease through numerous mechanisms, including regulation via posttranslational modifications. A specific posttranslational modification, the addition of
O
‐linked β‐
N
acetylglucosamine (
O
‐GlcNAcylation), has been implicated in molecular mechanisms of both physiological and pathologic adaptations. The current study aimed to test the hypothesis that in cardiomyocytes, sustained protein
O
‐GlcNAcylation contributes to cardiac adaptations, and its progression to pathophysiology.
Methods and Results
Using a naturally occurring dominant‐negative
O
‐GlcNAcase (dnOGA) inducible cardiomyocyte‐specific overexpression transgenic mouse model, we induced dnOGA in 8‐ to 10‐week‐old mouse hearts. We examined the effects of 2‐week and 24‐week dnOGA overexpression, which progressed to a 1.8‐fold increase in protein
O‐
GlcNAcylation. Two‐week increases in protein
O
‐GlcNAc levels did not alter heart weight or function; however, 24‐week increases in protein
O
‐GlcNAcylation led to cardiac hypertrophy, mitochondrial dysfunction, fibrosis, and diastolic dysfunction. Interestingly, systolic function was maintained in 24‐week dnOGA overexpression, despite several changes in gene expression associated with cardiovascular disease. Specifically, mRNA‐sequencing analysis revealed several gene signatures, including reduction of mitochondrial oxidative phosphorylation, fatty acid, and glucose metabolism pathways, and antioxidant response pathways after 24‐week dnOGA overexpression.
Conclusions
This study indicates that moderate increases in cardiomyocyte protein
O
‐GlcNAcylation leads to a differential response with an initial reduction of metabolic pathways (2‐week), which leads to cardiac remodeling (24‐week). Moreover, the mouse model showed evidence of diastolic dysfunction consistent with a heart failure with preserved ejection fraction. These findings provide insight into the adaptive versus maladaptive responses to increased
O‐
GlcNAcylation in heart.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Reference61 articles.
1. Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
2. WHO
. Global health estimates 2020: Deaths by cause age sex by country and region 2000–2019. 2020 Accessed February 15 2022. www.who.int/data/gho/data/themes/mortality‐and‐global‐health‐estimates/ghe‐leading‐causes‐of‐death.
3. The Failing Heart — An Engine Out of Fuel
4. Cardiac Energy Metabolism in Heart Failure
5. Mitochondrial protein hyperacetylation in the failing heart
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献